Propafenone is a synthetic antiarrhythmic active pharmaceutical ingredient (API) belonging to the Class IC antiarrhythmic group. It is primarily used for the management of certain cardiac rhythm disorders by acting on cardiac sodium channels and slowing conduction through the heart. Propafenone is identified by CAS Number 54063-53-5, with the molecular formula C21H27NO3 and molecular weight 341.45 g/mol.
Propafenone is a membrane-stabilizing antiarrhythmic compound with both sodium-channel-blocking and beta-adrenergic blocking properties. It is used in pharmaceutical formulations for the management of specific supraventricular arrhythmias and is available commercially in oral dosage forms.
The API is generally described as a white to almost white crystalline powder. Propafenone is practically insoluble in water and is soluble in several organic solvents.
Propafenone has the following chemical characteristics:
Propafenone contains a chiral center and pharmaceutical products may contain the racemic mixture unless a specific stereochemical form is defined.
Propafenone API is used in the manufacture of antiarrhythmic medicines for selected cardiac rhythm disorders.
Major applications include:
Propafenone is generally reserved for patients in whom its use is clinically appropriate, and its administration should follow approved prescribing information and medical supervision.
Propafenone primarily blocks fast sodium channels in cardiac tissue, reducing the rate of phase 0 depolarization and slowing cardiac conduction. It also has beta-adrenergic blocking activity.
These pharmacological effects help suppress abnormal electrical activity and reduce the occurrence of certain cardiac arrhythmias.
Quality control of Propafenone API is important to establish identity, assay, purity, and consistency. Analytical testing should be performed using validated procedures according to the applicable pharmacopoeial or approved API specification.
Typical quality-control testing may include:
The applicable specification should be selected according to the exact API form and current pharmacopoeial requirements.
Propafenone API manufacturing requires controlled chemical processing, qualified raw materials, impurity control, purification, drying, and validated analytical testing.
A quality-focused manufacturing process may include:
Propafenone API can be manufactured and tested according to applicable pharmaceutical standards, regulatory requirements, and customer-specific specifications.
Propafenone should be packed in suitable, tightly closed pharmaceutical containers that protect the API from moisture, contamination, and unsuitable environmental conditions.
Storage should follow the applicable stability data and approved product specification. Proper packaging and controlled transportation conditions help preserve API quality during storage and distribution.
Documentation for Propafenone API may include:
A reliable Propafenone API manufacturing source should maintain controlled production processes, validated analytical methods, impurity monitoring, batch traceability, and appropriate pharmaceutical documentation.
Propafenone is an established antiarrhythmic API used in pharmaceutical formulations for selected cardiac rhythm disorders. Consistent manufacturing, analytical characterization, and quality control help pharmaceutical manufacturers obtain API material suitable for formulation development and pharmaceutical production.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.2% |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 0.5% |
| Melting Point | 172–175°C |